Drugs / Low molecular weight heparin
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 42 trials | ||||||
| Phase 4 | NCT05604859 | Aug 2022 → Dec 2023 | — | Qin Ning | Unknown | No outcome recorded |
| Phase 4 | NCT03120715 | Jul 2016 → Jun 2017 | infertility disorder | Nanfang Hospital, Southern Medical University | Unknown | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT06484634 | Dec 2023 → May 2024 | pregnancy disorder with abortive outcome | RESnTEC, Institute of Research | Completed | No outcome recorded |
| Comparator or background therapy5 trials | ||||||
| Phase 1/2 | NCT00790842 Background | Jan 2009 → Sep 2017 | plasma cell myeloma | PrECOG, LLC. | Terminated | No outcome recorded Stop: Enrollment |
| Phase 4 | NCT04645550 Background | Nov 2020 → Dec 2023 | cirrhosis of liver, portal hypertension, splenic disorder, venous thromboembolism | Northern Jiangsu People's Hospital | Completed | No outcome recorded |
| Phase 4 | NCT02247414 Background | Sep 2014 → Sep 2017 | cirrhosis of liver, hypertensive disorder, portal vein thrombosis | Yangzhou University | Completed | No outcome recorded |
| — | NCT06937372 Comparator | Aug 2026 → Oct 2027 expected | venous thromboembolism | Queen Mary University of London | Not yet recruiting | No outcome recorded |
| — | NCT04394182 Background | Apr → Dec 2020 | cytokine release syndrome, viral pneumonia | Fundacion GenesisCare | Suspended | No outcome recorded Stop: Enrollment |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 8 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | low molecular weight heparin | “Heparin, low molecular weight heparin, or coumadin could be used if the patient was intolerant to aspirin.” NCT00790842 ↗ |
| Known as | LMWH | “A daily dose of 40 mg of low-molecular-weight heparin (LMWH) subcutaneously was given to the patients.” NCT06484634 ↗1“Low molecular weight heparin (LMWH)” NCT06937372 ↗ |
| Route | Subcutaneous | “patients will receive subcutaneous injection of Low Molecular Weight Heparin (4100 IU) once daily for first five days” NCT02247414 ↗ |